These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8485125

  • 1. Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparation.
    Yasuda T, Gold HK, Kohmura C, Guerrero L, Yaoita H, Fallon JT, Bunting S, Collen D.
    Arterioscler Thromb; 1993 May; 13(5):738-47. PubMed ID: 8485125
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
    Imura Y, Stassen JM, Bunting S, Stockmans F, Collen D.
    Blood; 1992 Sep 01; 80(5):1247-53. PubMed ID: 1515641
    [Abstract] [Full Text] [Related]

  • 3. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation.
    Yasuda T, Gold HK, Leinbach RC, Yaoita H, Fallon JT, Guerrero L, Napier MA, Bunting S, Collen D.
    Circulation; 1991 Mar 01; 83(3):1038-47. PubMed ID: 1900221
    [Abstract] [Full Text] [Related]

  • 4. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.
    Collen D, Lu HR, Stassen JM, Vreys I, Yasuda T, Bunting S, Gold HK.
    Thromb Haemost; 1994 Jan 01; 71(1):95-102. PubMed ID: 8165652
    [Abstract] [Full Text] [Related]

  • 5. G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogs.
    Lu HR, Gold HK, Wu Z, Yasuda T, Pauwels P, Rapold HJ, Napier M, Bunting S, Collen D.
    Thromb Haemost; 1992 Jun 01; 67(6):686-91. PubMed ID: 1509410
    [Abstract] [Full Text] [Related]

  • 6. Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase.
    Sabatine MS, Tu TM, Jang IK.
    J Thromb Thrombolysis; 2000 Oct 01; 10(2):189-96. PubMed ID: 11005941
    [Abstract] [Full Text] [Related]

  • 7. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
    Imura Y, Stassen JM, Vreys I, Lesaffre E, Gold HK, Collen D.
    Thromb Haemost; 1992 Sep 07; 68(3):336-40. PubMed ID: 1440501
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation.
    Yasuda T, Gold HK, Yaoita H, Leinbach RC, Guerrero JL, Jang IK, Holt R, Fallon JT, Collen D.
    J Am Coll Cardiol; 1990 Sep 07; 16(3):714-22. PubMed ID: 2117620
    [Abstract] [Full Text] [Related]

  • 9. A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons.
    Kohmura C, Gold HK, Yasuda T, Holt R, Nedelman MA, Guerrero JL, Weisman HF, Collen D.
    Arterioscler Thromb; 1993 Dec 07; 13(12):1837-42. PubMed ID: 8241105
    [Abstract] [Full Text] [Related]

  • 10. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
    Sitko GR, Ramjit DR, Stabilito II, Lehman D, Lynch JJ, Vlasuk GP.
    Circulation; 1992 Feb 07; 85(2):805-15. PubMed ID: 1735171
    [Abstract] [Full Text] [Related]

  • 11. Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist.
    Lucchessi BR, Rote WE, Driscoll EM, Mu DX.
    Br J Pharmacol; 1994 Dec 07; 113(4):1333-43. PubMed ID: 7889289
    [Abstract] [Full Text] [Related]

  • 12. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    Roux SP, Tschopp TB, Kuhn H, Steiner B, Hadváry P.
    J Pharmacol Exp Ther; 1993 Jan 07; 264(1):501-8. PubMed ID: 8423548
    [Abstract] [Full Text] [Related]

  • 13. Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis.
    Shebuski RJ, Stabilito IJ, Sitko GR, Polokoff MH.
    Circulation; 1990 Jul 07; 82(1):169-77. PubMed ID: 2114233
    [Abstract] [Full Text] [Related]

  • 14. Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosis.
    Ziskind AA, Gold HK, Yasuda T, Kanke M, Guerrero JL, Fallon JT, Saito T, Collen D.
    Circulation; 1989 Feb 07; 79(2):393-9. PubMed ID: 2492455
    [Abstract] [Full Text] [Related]

  • 15. Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.
    Yasuda T, Gold HK, Leinbach RC, Saito T, Guerrero JL, Jang IK, Holt R, Fallon JT, Collen D.
    J Am Coll Cardiol; 1990 Dec 07; 16(7):1728-35. PubMed ID: 2123910
    [Abstract] [Full Text] [Related]

  • 16. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
    Yao SK, Ober JC, Ferguson JJ, Anderson HV, Maraganore J, Buja LM, Willerson JT.
    Circulation; 1992 Dec 07; 86(6):1993-9. PubMed ID: 1451271
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK.
    Circulation; 1994 Jan 07; 89(1):3-12. PubMed ID: 8281661
    [Abstract] [Full Text] [Related]

  • 18. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ, Prager NA, Sobel BE, Abendschein DR.
    Circulation; 1991 Mar 07; 83(3):1048-56. PubMed ID: 1900222
    [Abstract] [Full Text] [Related]

  • 19. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
    Lewis GD, Witzke C, Colon-Hernandez P, Guerrero JL, Bloch KD, Semigran MJ.
    J Am Coll Cardiol; 2006 Apr 04; 47(7):1471-7. PubMed ID: 16580539
    [Abstract] [Full Text] [Related]

  • 20. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
    Gold HK, Coller BS, Yasuda T, Saito T, Fallon JT, Guerrero JL, Leinbach RC, Ziskind AA, Collen D.
    Circulation; 1988 Mar 04; 77(3):670-7. PubMed ID: 3124974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.